Concepedia

Alise Reicin

AR

Statistics

Publications

34

Citations

7.4K

H-Index

27

Active since

1984

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

University of Southern California

Columbia University

University of Nottingham

University of Toronto

Alise Reicin is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacotherapy, and pharmacology.

Publications per year

1984–2012

34

Publications

34

Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis

Claire Bombardier, Loren Laine, Alise Reicin et al. · New England Journal of Medicine · 2000 · 4K citations · Full text

, , +8

Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison

Christopher P. Cannon, Sean Curtis, Garret A. FitzGerald et al. · The Lancet · 2006 · 521 citations

, , +12

Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use

Loren Laine, L. Connors, Alise Reicin et al. · Gastroenterology · 2003 · 356 citations · Full text

, , +10

Lung eQTLs to Help Reveal the Molecular Underpinnings of Asthma

Ke Hao, Yohan Bossé, David C. Nickle et al. · PLoS Genetics · 2012 · 331 citations · Full text

, , +17

Stratifying the risk of NSAID-related upper gastrointestinal clinical events: Results of a double-blind outcomes study in patients with rheumatoid arthritis

Loren Laine, Claire Bombardier, Christopher J. Hawkey et al. · Gastroenterology · 2002 · 263 citations · Full text

, , +14

1–5 of 34